Catalyst Pharmaceuticals
CPRX
#4011
Rank
HK$24.00 B
Marketcap
HK$195.27
Share price
-2.58%
Change (1 day)
17.39%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Cash on Hand

Cash on Hand as of December 2025 : HK$5.55 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company has HK$5.55 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalyst Pharmaceuticals - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$5.51 B37.33%
2024-12-31HK$4.01 B273.79%
2023-12-31HK$1.07 B-53.89%
2022-12-31HK$2.33 B56.32%
2021-12-31HK$1.49 B37.15%
2020-12-31HK$1.08 B47.73%
2019-12-31HK$0.73 B75.77%
2018-12-31HK$0.41 B-36.2%
2017-12-31HK$0.65 B109.49%
2016-12-31HK$0.31 B-30.77%
2015-12-31HK$0.45 B48.58%
2014-12-31HK$0.30 B65.69%
2013-12-31HK$0.18 B53.86%
2012-12-31HK$0.11 B155.2%
2011-12-31HK$46.82 M9.9%
2010-12-31HK$42.6 M-29.36%
2009-12-31HK$60.31 M-33.66%
2008-12-31HK$90.92 M-26.86%
2007-12-31HK$0.12 B-21.78%
2006-12-31HK$0.15 B2558.25%
2005-12-31HK$5.97 M318.33%
2004-12-31HK$1.42 M
2002-12-31HK$0.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$157.39 B 2,734.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$106.45 B 1,817.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$69.98 B 1,160.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$7.35 B 32.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$73.31 M-98.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$12.21 B 120.06%๐Ÿ‡บ๐Ÿ‡ธ USA